proxyvotesnow.com

Home › Asset managers › Direxion Shares ETF Trust › 2024-2025 › Against the board

Direxion Shares ETF Trust 2024-2025: where it broke with the board

Two kinds of vote are listed: a board-sponsored proposal Direxion Shares ETF Trust voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.

Everything Only shareholder proposals it backed

729 proposals.

Direxion Shares ETF Trust, 2024-2025 proxy season. Who put a proposal on the ballot is taken from its N-PX category; see the method note on the overview page.
CompanyMeetingProposalCategory On the ballot fromDirexion Shares ETF Trust votedFunds
ARS Pharmaceuticals, Inc. 2025-06-25 To elect the four nominees for Class II director named in the proxy statement to serve for three-year terms until the 2028 Annual Meeting of Stockholders: Richard Lowenthal Director Elections Board ABSTAIN 1
Agios Pharmaceuticals, Inc. 2025-06-18 To approve an amendment to the Agios Pharmaceuticals, Inc. 2023 Stock Incentive Plan, to increase the number of shares of common stock available thereunder by 2,500,000 shares. Compensation Board AGAINST 1
Air Transport Services Group, Inc. 2025-02-10 To approve, by advisory (non-binding) vote, the compensation that may be paid or become payable to the Company's named executive officers in connection with the consummation of the merger (the "Advisory Compensation Proposal"); and Say-on-Pay Board AGAINST 1
Akero Therapeutics, Inc. 2025-06-03 To elect two class III directors, Judy Chou, Ph.D. and Tomas Heyman, to our board of directors, to serve until the 2028 Annual Meeting of stockholders and until her or his successor has been duly elected and qualified, or until her or his earlier death, resignation or removal: Judy Chou, Ph.D. Director Elections Board ABSTAIN 1
Alarm.com Holdings, Inc. 2025-06-04 To approve the Alarm.com Holdings, Inc. 2025 Equity Incentive Plan. Compensation Board AGAINST 1
Allegiant Travel Company 2025-06-26 Approval of an amendment to the Allegiant Travel Company 2022 Long-Term Incentive Plan. Compensation Board AGAINST 1
Ally Financial Inc. 2025-05-06 Advisory vote on executive compensation. Say-on-Pay Board AGAINST 1
Altice USA, Inc. 2025-06-11 Election of Directors: Charles Stewart Director Elections Board AGAINST 1
Altice USA, Inc. 2025-06-11 Election of Directors: David Drahi Director Elections Board AGAINST 1
Altice USA, Inc. 2025-06-11 Election of Directors: Dennis Mathew Director Elections Board AGAINST 1
Altice USA, Inc. 2025-06-11 Election of Directors: Dennis Okhuijsen Director Elections Board AGAINST 1
Altice USA, Inc. 2025-06-11 Election of Directors: Dexter Goei Director Elections Board AGAINST 1
Altice USA, Inc. 2025-06-11 Election of Directors: Mark Mullen Director Elections Board AGAINST 1
Altice USA, Inc. 2025-06-11 Election of Directors: Patrick Drahi Director Elections Board AGAINST 1
Altice USA, Inc. 2025-06-11 Election of Directors: Raymond Svider Director Elections Board AGAINST 1
Altice USA, Inc. 2025-06-11 Election of Directors: Susan Schnabel Director Elections Board AGAINST 1
Altice USA, Inc. 2025-06-11 To approve, in an advisory vote, the compensation of the Company's named executive officers. Say-on-Pay Board AGAINST 1
Altimmune, Inc. 2024-09-26 Hold an advisory vote on the compensation of the Company's named executive officers as disclosed in the attached Proxy Statement. Say-on-Pay Board AGAINST 1
Amneal Pharmaceuticals, Inc. 2025-05-06 Election of Directors: Paul Meister Director Elections Board AGAINST 1
AnaptysBio, Inc. 2025-06-17 To approve an amendment to our 2017 Equity Incentive Plan. Compensation Board AGAINST 1
AnaptysBio, Inc. 2025-06-17 To conduct a non-binding advisory vote on the compensation of our named executive officers as disclosed in the accompanying materials. Say-on-Pay Board AGAINST 1
AnaptysBio, Inc. 2025-06-17 To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal: Rita Jain, M.D. Director Elections Board ABSTAIN 1
Anavex Life Sciences Corp. 2025-06-10 To approve an amendment to the Company's 2022 Omnibus Incentive Plan. Compensation Board AGAINST 1
Antero Midstream Corporation 2025-06-04 Class III Nominees: David H. Keyte Director Elections Board ABSTAIN 1
Antero Midstream Corporation 2025-06-04 Class III Nominees: Nancy E. Chisholm Director Elections Board ABSTAIN 1
Apogee Therapeutics, Inc. 2025-06-17 Election of Class II Directors for terms expiring in 2028: Lisa Bollinger, M.D. Director Elections Board ABSTAIN 1
Apogee Therapeutics, Inc. 2025-06-17 Election of Class II Directors for terms expiring in 2028: Nimish Shah Director Elections Board ABSTAIN 1
AppFolio, Inc. 2025-06-13 Election of Class I Directors: Janet Kerr Director Elections Board ABSTAIN 1
AppLovin Corporation 2025-06-04 Election of Directors: ADAM FOROUGHI Director Elections Board ABSTAIN 1
AppLovin Corporation 2025-06-04 Election of Directors: ALYSSA HARVEY DAWSON Director Elections Board ABSTAIN 1
AppLovin Corporation 2025-06-04 Election of Directors: BARBARA MESSING Director Elections Board ABSTAIN 1
AppLovin Corporation 2025-06-04 Election of Directors: HERALD CHEN Director Elections Board ABSTAIN 1
AppLovin Corporation 2025-06-04 Election of Directors: MARGARET GEORGIADIS Director Elections Board ABSTAIN 1
Archer Aviation Inc. 2025-06-27 Approval, on a non-binding advisory basis, of the compensation of our named executive officers. Say-on-Pay Board AGAINST 1
Archer Aviation Inc. 2025-06-27 Election of Class I Directors: Deborah Diaz Director Elections Board ABSTAIN 1
Arcus Biosciences, Inc. 2025-06-10 Election of Directors: Antoni Ribas, M.D., Ph.D. Director Elections Board ABSTAIN 1
Arcus Biosciences, Inc. 2025-06-10 Election of Directors: Patrick Machado, J.D. Director Elections Board ABSTAIN 1
Arcutis Biotherapeutics, Inc. 2025-06-12 Election of Class II directors to hold office until the 2028 Annual Meeting of Stockholders or until their successors are elected: Bhaskar Chaudhuri, Ph.D. Director Elections Board ABSTAIN 1
Arcutis Biotherapeutics, Inc. 2025-06-12 To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay Board AGAINST 1
Ardelyx, Inc. 2025-06-18 To approve the Amendment to the Amended and Restated 2014 Equity Incentive Award Plan; and Compensation Board AGAINST 1
Ardelyx, Inc. 2025-06-18 To elect two Class II directors to hold office until the 2028 Annual Meeting of Stockholders and until their successors are elected and qualified: David Mott Director Elections Board ABSTAIN 1
Arhaus, Inc. 2025-05-15 To elect four Directors, each to serve a three-year term: Albert Adams Director Elections Board ABSTAIN 1
Arhaus, Inc. 2025-05-15 To elect four Directors, each to serve a three-year term: John Kyees Director Elections Board ABSTAIN 1
Arhaus, Inc. 2025-05-15 To elect four Directors, each to serve a three-year term: John M. Roth Director Elections Board ABSTAIN 1
Arm Holdings Plc 2024-09-11 Approve Employee Stock Purchase Plan Compensation Board AGAINST 1
Arm Holdings Plc 2024-09-11 Elect Jeffrey Sine as Director Director Elections Board AGAINST 1
Arm Holdings Plc 2024-09-11 Elect Masayoshi Son as Director Director Elections Board AGAINST 1
Arm Holdings Plc 2024-09-11 Elect Rene Haas as Director Director Elections Board AGAINST 1
Arm Holdings Plc 2024-09-11 Elect Ronald Fisher as Director Director Elections Board AGAINST 1
ArriVent BioPharma, Inc. 2025-06-18 Election of Directors: Kristine Peterson Director Elections Board ABSTAIN 1
ArriVent BioPharma, Inc. 2025-06-18 Election of Directors: Zhengbin (Bing) Yao, Ph.D. Director Elections Board ABSTAIN 1
Arvinas, Inc. 2025-06-25 Election of three Class I directors: John Houston, Ph.D. Director Elections Board ABSTAIN 1
Arvinas, Inc. 2025-06-25 Election of three Class I directors: Laurie Smaldone Alsup, M.D. Director Elections Board ABSTAIN 1
Arvinas, Inc. 2025-06-25 Election of three Class I directors: Linda Bain Director Elections Board ABSTAIN 1
AvePoint, Inc. 2025-05-06 Election of Directors: Janet Schijns Director Elections Board ABSTAIN 1
Avidity Biosciences, Inc. 2025-06-10 To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission; and Say-on-Pay Board AGAINST 1
Axos Financial, Inc. 2024-11-14 Election of Directors: Paul J. Grinberg Director Elections Board ABSTAIN 1
Axos Financial, Inc. 2024-11-14 To approve in a non-binding and advisory vote, the compensation of the Company's Named Executive Officers as disclosed in this Proxy Statement. Say-on-Pay Board AGAINST 1
Axsome Therapeutics, Inc. 2025-06-06 Election of Director: Roger Jeffs, Ph.D. Director Elections Board ABSTAIN 1
Axsome Therapeutics, Inc. 2025-06-06 To approve the Company's 2025 Long-Term Incentive Plan. Compensation Board AGAINST 1
BOK Financial Corporation 2025-04-29 Election of Directors: Alan S. Armstrong Director Elections Board ABSTAIN 1
BOK Financial Corporation 2025-04-29 Election of Directors: Chester E. Cadieux, III Director Elections Board ABSTAIN 1
BOK Financial Corporation 2025-04-29 Election of Directors: Claudia S. San Pedro Director Elections Board ABSTAIN 1
BOK Financial Corporation 2025-04-29 Election of Directors: E. Carey Joullian, IV Director Elections Board ABSTAIN 1
BOK Financial Corporation 2025-04-29 Election of Directors: George B. Kaiser Director Elections Board ABSTAIN 1
BOK Financial Corporation 2025-04-29 Election of Directors: John W. Coffey Director Elections Board ABSTAIN 1
BOK Financial Corporation 2025-04-29 Election of Directors: Stacy C. Kymes Director Elections Board ABSTAIN 1
BOK Financial Corporation 2025-04-29 Election of Directors: Stanley A. Lybarger Director Elections Board ABSTAIN 1
Berry Global Group, Inc. 2025-02-25 Proposal to approve, on a non-binding, advisory basis, the compensation that may be paid or become payable to Berry's named executive officers that is based on or otherwise relates to the transactions contemplated by the Merger Agreement, which proposal is referred to as the "Berry Advisory Compensation Proposal." Say-on-Pay Board AGAINST 1
Bill Holdings, Inc. 2024-12-05 To approve, on an advisory basis, the compensation of our Named Executive Officers (Say-on-Pay). Say-on-Pay Board AGAINST 1
Bill Holdings, Inc. 2024-12-05 To elect the directors listed below: Aida Alvarez Director Elections Board ABSTAIN 1
BioCryst Pharmaceuticals, Inc. 2025-06-12 To approve an amended and restated Stock Incentive Plan, increasing the number of shares available for issuance under the Stock Incentive Plan. Compensation Board AGAINST 1
Biohaven Ltd. 2025-05-05 Election of Directors for a term expiring at the 2028 Annual Meeting of shareholders: Vlad Coric, M.D. Director Elections Board AGAINST 1
BlackLine, Inc. 2025-05-08 Election of Directors: Barbara Whye Director Elections Board ABSTAIN 1
Blend Labs, Inc. 2025-06-11 The election of the following director nominees: Eric Woersching Director Elections Board ABSTAIN 1
Blend Labs, Inc. 2025-06-11 The election of the following director nominees: Gerald Chen Director Elections Board ABSTAIN 1
Blend Labs, Inc. 2025-06-11 The election of the following director nominees: Nima Ghamsari Director Elections Board ABSTAIN 1
Blueprint Medicines Corporation 2025-06-18 Election of class I directors each to serve for a three-year term, or until their successor has been duly elected and qualified: Jeffrey Albers Director Elections Board ABSTAIN 1
BridgeBio Pharma, Inc. 2025-06-20 To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 5,000,000 shares. Compensation Board AGAINST 1
BridgeBio Pharma, Inc. 2025-06-20 To cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers. Say-on-Pay Board AGAINST 1
Brookline Bancorp, Inc. 2025-05-21 A proposal to approve, on a non-binding advisory basis, the compensation that may become payable to the named executive officers of Brookline in connection with the Mergers (the "Brookline Merger-Related Compensation Proposal"). Say-on-Pay Board AGAINST 1
Bruker Corporation 2025-05-29 Approval of the adoption of the Bruker Corporation 2026 Incentive Compensation Plan. Compensation Board AGAINST 1
C3.ai, Inc. 2024-10-02 Advisory vote to approve the compensation of our named executive officers. Say-on-Pay Board AGAINST 1
C3.ai, Inc. 2024-10-02 Election of Class I Directors: KR Sridhar Director Elections Board ABSTAIN 1
C3.ai, Inc. 2024-10-02 Election of Class I Directors: Thomas M. Siebel Director Elections Board ABSTAIN 1
CG Oncology, Inc. 2025-06-05 To elect the Board's three nominees for Class I director named as nominees to hold office until the 2028 Annual Meeting of Stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Arthur Kuan Director Elections Board ABSTAIN 1
CRISPR Therapeutics AG 2025-06-05 4.b Re-election of Ali Behbahani, M.D. Director Elections Board AGAINST 1
CRISPR Therapeutics AG 2025-06-05 6.b Binding vote on maximum equity for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders. Compensation Board AGAINST 1
CRISPR Therapeutics AG 2025-06-05 6.c Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2025 to June 30, 2026. Compensation Board AGAINST 1
CRISPR Therapeutics AG 2025-06-05 6.d Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2025. Compensation Board AGAINST 1
CRISPR Therapeutics AG 2025-06-05 6.e Binding vote on maximum equity for members of the Executive Committee from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders. Compensation Board AGAINST 1
CRISPR Therapeutics AG 2025-06-05 6.f Non-binding advisory vote on the 2024 Compensation Report. Compensation Board AGAINST 1
CRISPR Therapeutics AG 2025-06-05 Election or Re-election of the members of the Compensation Committee: 5.a Re-election of Ali Behbahani, M.D. Director Elections Board AGAINST 1
CRISPR Therapeutics AG 2025-06-05 Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements. Say-on-Pay Board AGAINST 1
CVR Energy, Inc. 2025-06-05 To approve the Third Amended & Restated CVR Energy, Inc. 2007 Long-Term Incentive Plan. Compensation Board AGAINST 1
CVR Energy, Inc. 2025-06-05 To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay Board AGAINST 1
Capricor Therapeutics, Inc. 2025-05-22 APPROVAL OF THE CAPRICOR THERAPEUTICS 2025 EQUITY INCENTIVE PLAN. Compensation Board AGAINST 1
Capricor Therapeutics, Inc. 2025-05-22 ELECTION OF DIRECTORS: Karimah Es Sabar Director Elections Board ABSTAIN 1
CareDx, Inc. 2025-06-12 Approval of an amendment to 2024 Equity incentive Plan. Compensation Board AGAINST 1
Cava Group, Inc. 2025-06-20 Election of Class II Directors: Benjamin Felt Director Elections Board ABSTAIN 1

← Previous Page 4 of 8 Next →

← Back to Direxion Shares ETF Trust 2024-2025 overview

Built 2026-10-04 from SEC Form N-PX filings.